Dr. Fakhar Khan, Distinguished Consultant Cardiologist, Joins UK Clinical Board for PMcardio
We are thrilled to announce the latest addition to our UK Clinical Board, Dr. Fakhar Khan, an award-winning Consultant Cardiologist with a profound understanding of the unique demands of the UK’s healthcare landscape.
We are thrilled to announce the latest addition to our UK Clinical Board, Dr. Fakhar Khan, an award-winning Consultant Cardiologist with a profound understanding of the unique demands of the UK’s healthcare landscape.
Currently serving at St Bartholomew’s Hospital’s Barts Heart Centre and the Royal Free Hospital in Hamstead, Dr. Khan brings unparalleled expertise in managing heart rhythm disorders. His deep understanding of the healthcare system in the UK, strengthened by his extensive training at Oxford, Papworth Hospital, and Addenbrooke’s Hospital, coupled with his experience at prestigious healthcare centres, equips him with unique insights that will immensely benefit our board’s decision-making process.
An acclaimed medical researcher, Dr. Khan has made remarkable strides in improving patient outcomes, including leading a major clinical trial at Cambridge University. His numerous peer-reviewed articles and insightful speeches at international conferences in the US and Europe underscore his dedication to advancing healthcare.
Recognised by the Heart Rhythm Society UK with the Young Investigator Award in 2010 and the prestigious Ralph Noble Prize from the University of Cambridge, Dr. Khan’s work truly stands out in the field of clinical medicine.
With his blend of clinical expertise, research prowess, and an intrinsic understanding of the UK healthcare system, we are confident that Dr. Khan will be an invaluable asset to our UK Clinical Board. We eagerly anticipate the innovative insights and guidance he will bring to our team.
About Dr. Fakhar Khan Dr. Fakhar Khan is a Consultant Cardiologist specializing in heart rhythm disorders, currently serving at the Barts Heart Centre and the Royal Free Hospital. With his medical degree from the University of Cambridge and additional training across renowned institutions, he brings a unique blend of clinical expertise and research acumen. As an esteemed researcher and recipient of significant awards such as the Young Investigator Award and the Ralph Noble Prize, Dr. Khan’s contributions significantly impact the landscape of clinical medicine.
Share this article
About PMcardio
PMcardio features CE-certified AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.
